MedMira Inc. (TSXV:MIR)
Canada · Delayed Price · Currency is CAD 0.0600
+0.0050 (8.33%)
Feb 6, 2026, 1:53 PM EST
MedMira Market Cap
MedMira has a market cap or net worth of CAD 45.33 million as of February 9, 2026. Its market cap has decreased by -21.38% in one year.
Market Cap
45.33M
Enterprise Value
62.41M
Revenue
232.99K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since June 30, 2000, MedMira's market cap has decreased from 81.66M to 45.33M, a decrease of -44.49%. That is a compound annual growth rate of -2.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 45.33M | -0.61% |
| Dec 31, 2025 | 45.61M | -31.58% |
| Dec 31, 2024 | 66.66M | -13.11% |
| Dec 29, 2023 | 76.72M | 37.50% |
| Dec 30, 2022 | 55.80M | -60.00% |
| Dec 31, 2021 | 139.49M | -13.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medicenna Therapeutics | 68.40M |
| ME Therapeutics Holdings | 68.21M |
| Sharp Therapeutics | 66.17M |
| NurExone Biologic | 58.04M |
| Sernova Biotherapeutics | 52.56M |
| BriaCell Therapeutics | 35.96M |
| Defence Therapeutics | 35.00M |
| Resverlogix | 33.09M |